Diethyldithiocarbamate, an anti-abuse drug, alleviates steatohepatitis and fibrosis in rodents
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113843
下载链接
链接失效反馈官方服务：
资源简介：
C57BL/6 mice received methionine/choline deficient (MCD) diet to establish the model of non-alcoholic fatty liver disease (NAFLD) with or without Diethyldithiocarbamate (DDC) treatment. DDC improves hepatic steatosis, ballooning, inflammation and fibrosis in rodent models of NAFLD through modulating lipid metabolism and oxidative stress. In this study, mRNA in liver tissues from 2 normal control mice, 3 MCD-induced mice and 3 MCD-induced mice with DDC treatment were analyzed by microarray.
创建时间：
2018-12-26
